These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1980362)

  • 21. Presynaptic receptors for dopamine, histamine, and serotonin.
    Feuerstein TJ
    Handb Exp Pharmacol; 2008; (184):289-338. PubMed ID: 18064418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Pope-Coleman A; Tinker JP; Schneider JS
    Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of the brain dopaminergic mechanisms in different models of anxiety states].
    Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Chernikov AV; Shevchenko SL
    Fiziol Zh Im I M Sechenova; 1992 Dec; 78(12):70-7. PubMed ID: 1363996
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of D1 and D2 receptors in the regulation of intraocular pressure.
    Spampinato D; Cavaliere S; Dal Bello A; Caruso P; Marino V; Drago F
    Pharmacol Res; 1990; 22 Suppl 1():57-8. PubMed ID: 1980948
    [No Abstract]   [Full Text] [Related]  

  • 26. Magnetic fields and the habenular complex.
    Sandyk R; Anninos PA; Tsagas N
    Int J Neurosci; 1991 Aug; 59(4):263-6. PubMed ID: 1683343
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.
    Miller DD; Harrold M; Wallace RA; Wallace LJ; Uretsky NJ
    Trends Pharmacol Sci; 1988 Aug; 9(8):282-4. PubMed ID: 2907954
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopaminergic drug-receptor interactions.
    Scott JE
    Trends Pharmacol Sci; 1989 Jan; 10(1):14-5. PubMed ID: 2574508
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrinsic activity of DA agonists.
    Lahti RA; Figur LM; Piercey MF; Ruppel PL; Evans DL
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():182A-183A. PubMed ID: 1354024
    [No Abstract]   [Full Text] [Related]  

  • 30. Symposium papers presented at the symposium on Receptors of dopamine antagonists: new biochemical approaches. Beerse, Belgium, July 6--8, 1978.
    Life Sci; 1978 Oct; 23(17-18):1745-879. PubMed ID: 31530
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic applications of drugs acting on peripheral dopamine receptors.
    Horn PT; Murphy MB
    J Clin Pharmacol; 1990 Aug; 30(8):674-9. PubMed ID: 1976128
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.
    Waddington JL
    Gen Pharmacol; 1988; 19(1):55-60. PubMed ID: 3278946
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopaminergic control of aldosterone secretion. State-of-the-art review.
    Cuche JL
    Fundam Clin Pharmacol; 1988; 2(4):327-39. PubMed ID: 2906035
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current developments in the pharmacology of dopaminergic receptors (I)].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121
    [No Abstract]   [Full Text] [Related]  

  • 35. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.
    Fuxe K; Ungerstedt U
    Med Biol; 1974 Feb; 52(1):48-54. PubMed ID: 4157329
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current developments in the pharmacology of dopaminergic receptors (II)].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):393-4. PubMed ID: 2573123
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current developments in the pharmacology of the dopaminergic receptors. III].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889
    [No Abstract]   [Full Text] [Related]  

  • 38. Repeated administrations of dopamine receptor agents affect lithium-induced state-dependent learning in mice.
    Zarrindast M; Madadi F; Ahmadi S
    J Psychopharmacol; 2009 Aug; 23(6):645-51. PubMed ID: 18635706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor agonists and antagonists.
    Kohli JD
    Proc West Pharmacol Soc; 1990; 33():21-7. PubMed ID: 1980362
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.